LEM Surgical showcases its Dynamis robotic system and AI roadmap at CES 2026

LEM Surgical presented its Dynamis robotic platform at CES 2026, highlighting its clinical deployment in the U.S. and outlining a new development roadmap integrating NVIDIA’s physical AI technologies.

Bern-based medtech company LEM Surgical showcased its Dynamis Robotic Surgical System at CES 2026 in Las Vegas, marking a new phase in the evolution of its robotic platform. Already FDA 510(k) cleared and in routine clinical use in the United States, the system is now positioned for further development through the integration of advanced physical artificial intelligence technologies.

LEM Surgical used CES to highlight the commercial reality of Dynamis, which is currently deployed for spinal procedures at Southern Hills Hospital & Medical Center. Unlike many medical technologies presented at the event, Dynamis is already being used in live clinical settings, following the company’s recent completion of its first U.S. clinical procedures. The system is designed around a dual-arm architecture that enables coordinated, bimanual operation, reflecting the workflow and dexterity of a human surgeon.

From clinical deployment to AI-driven development

At CES, LEM Surgical also outlined its roadmap for the next generation of the Dynamis system, built around the integration of physical AI technologies from NVIDIA. Future iterations will leverage platforms such as NVIDIA Jetson Thor and NVIDIA Isaac for Healthcare to enhance autonomy, perception and real-time adaptability in complex surgical environments. The company aims to continuously train its robotic systems using open-world AI models, supporting more precise and context-aware assistance during procedures.

Headquartered in Bern with commercial operations in the United States, LEM Surgical continues to combine Swiss engineering with international clinical deployment, positioning its robotic platform at the intersection of surgical practice and emerging AI-driven technologies.